SCHEMBL874338

SCHEMBL874338

O=CN1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519076 0.92
SCHEMBL15062197 0.90 ALDH1A1 (0.40)
SCHEMBL13649507 0.90 ALDH1A1 (0.40)
SCHEMBL2530269 0.90 ALDH1A1 (0.40)
SCHEMBL10565094 0.83
SCHEMBL5473091 0.77 BRD4 (0.42)
SCHEMBL10869 0.77
SCHEMBL7805829 0.77
SCHEMBL3239145 0.77
SCHEMBL649628 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118546008-A Hollow carbon fiber reinforced carbon aerogel composite material and preparation method and application thereof 东华大学 2024-08-27 CN claimed
CN-117897392-A Aqueous solid phase peptide synthesis 多肽实验室(PPL)控股公司 2024-04-16 CN claimed
CN-115960007-A Preparation method of sitagliptin intermediate by using nitrogen-containing formyl catalyst 浙江大学 2023-04-14 CN claimed
EP-3356375-B1 PROCESS FOR RECOVERING A MIXTURE COMPRISING A (THIO)PHOSPHORIC ACID DERIVATIVE BASF SE (DE) 2023-01-04 EP claimed
CN-110997670-A [1,2,4] triazolo [4,3-a ] pyridyl substituted indole compounds 百时美施贵宝公司 2020-04-10 CN claimed
US-9834548-B2 Pyridazine compounds as JAK inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2017-12-05 US claimed
US-20170174673-A1 PYRIDAZINE COMPOUNDS AS JAK INHIBITORS ALEXION PHARMACEUTICALS, INC. 2017-06-22 US claimed
EP-2949644-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS Paratek Pharmaceuticals, Inc. (US) 2015-12-02 EP claimed
WO-2015123453-A1 PYRIDAZINE COMPOUNDS AS JAK INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2015-08-20 WO claimed
US-20140309192-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC, 2014-10-16 US claimed
EP-1807387-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS Paratek Pharmaceuticals, Inc. (US) 2007-07-18 EP claimed
US-20060166945-A1 Substituted tetracycline compounds PARATEK PHARMACEUTICALS, INC. (US) 2006-07-27 US claimed
WO-2006047756-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2006-05-04 WO claimed
EP-1140802-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINES BOEHRINGER INGELHEIM PHARMA (DE) 2004-03-17 EP claimed
EP-1086949-B1 Process for the preparation of isochroman-3-ones CLARIANT GMBH (DE) 2003-02-19 EP claimed
WO-1996032403-A2 NOVEL CYTOSINE AND CYTIDINE DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 1996-10-17 WO claimed
US-4863903-A RENIN ENZYME INHIBITORS, HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1989-09-05 US claimed
EP-0230242-A2 Substituted derivatives of 4-amino-3-hydroxy-butyric acid, process for their production, medicines containing them, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-07-29 EP claimed
EP-0144290-A2 Substituted ethylenediamine derivatives CIBA-GEIGY AG (CH) 1985-06-12 EP claimed
EP-0037990-B1 PHENYL QUINOLIZIDINES, CORRESPONDING PHARMACEUTICAL PREPARATIONS, THE PREPARATION OF THE ACTIVE COMPOUNDS AND CORRESPONDING STARTING COMPOUNDS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-12-05 EP claimed